MAPT and Alzheimer disease: These studies focus on the fact that insulin signalling also plays an important role in the brain, and that T2DM and AD seem to share a number of pathophysiological processes such as amyloid β plaques, disturbed cerebral glucose metabolism, tau hyperphosphorylation, and inflammation [18, 23–26].